The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug‐resistance in hepatocellular carcinoma
2018 ◽
Vol 503
(3)
◽
pp. 2124-2131
◽
2017 ◽
Vol 491
(1)
◽
pp. 178-182
◽
2019 ◽
Vol 111
◽
pp. 993-1004
◽